Table 2 Surgical and clinicopathologic data
From: Chemoradiation with adjuvant hysterectomy for stage IB-2 cervical cancer: a 10-year experience
Factors | Mean ± SD or absolute number | Range or percentage |
|---|---|---|
Operative time (min) | 62 ± 15 | 37–112 |
EBL (mL) | 187 ± 103 | 50–600 |
Transfusions (perioperative) | 4 | 6% |
Length of stay (days) | 3.13 ± 1.03 | 2–7 |
Lymph node count (common iliac/aortic) | 6.32 ± 2.94 | 2–15 |
Residual disease | 35 | 51% |
Positive margins | 2 | 3% |
Adjuvant therapya | 20 | 29% |